DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - Adverse Event Reports - Life Threatening Events - Guillain-Barre Syndrome

 



Index of reports > Cases resulting in life threatening events (13) > Cases with Guillain-Barre Syndrome (3)

Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in life threatening events where reactions include guillain-barre syndrome.

Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-02-20

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /; Diane



Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-01-23

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Guillain-Barre Syndrome, Cytomegalovirus Infection, Muscle Spasms, Organ Failure

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /



Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-01-16

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Death, Guillain-Barre Syndrome, Muscle Spasms

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009